Quent Capital LLC Sells 281 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Quent Capital LLC lowered its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,515 shares of the company’s stock after selling 281 shares during the period. Quent Capital LLC’s holdings in Acadia Healthcare were worth $139,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Sanctuary Advisors LLC acquired a new stake in shares of Acadia Healthcare in the second quarter valued at approximately $417,000. GAMMA Investing LLC increased its holdings in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares in the last quarter. Inspire Investing LLC increased its holdings in shares of Acadia Healthcare by 27.2% in the third quarter. Inspire Investing LLC now owns 6,647 shares of the company’s stock valued at $421,000 after purchasing an additional 1,421 shares in the last quarter. Raymond James & Associates increased its holdings in shares of Acadia Healthcare by 24.8% in the third quarter. Raymond James & Associates now owns 124,202 shares of the company’s stock valued at $7,876,000 after purchasing an additional 24,709 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new stake in shares of Acadia Healthcare in the third quarter valued at approximately $86,000.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price target for the company from $45.00 to $75.00 in a report on Thursday, December 12th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $64.00 target price on shares of Acadia Healthcare in a report on Friday, January 10th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, KeyCorp raised shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $41.28 on Thursday. Acadia Healthcare Company, Inc. has a 12-month low of $36.50 and a 12-month high of $87.77. The firm has a market capitalization of $3.83 billion, a price-to-earnings ratio of 13.53, a price-to-earnings-growth ratio of 1.75 and a beta of 1.30. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a fifty day moving average of $42.08 and a 200-day moving average of $54.33.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.